Marshall Wace North America’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Marshall Wace North America’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	$637K	Buy	+19,689	New	+$584K	0.01%	482

Other funds holding ISEE

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

Clarus Ventures Cambridge, Massachusetts $425M AUM 26.13% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Independence Capital Asset Partners Denver, Colorado $9.3M AUM 28.89% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

JHL Capital Group Chicago, Illinois $805M AUM 50.84% 1-Year Est. Return

Marshall Wace North America's ISEE Position: Q4 2013 in Review

Marshall Wace North America opened a new position in IVERIC bio, Inc. Common Stock (ISEE) in Q4 2013: 19,689 shares worth $637K. The stake represents 0.01% of the portfolio and ranks #482 among its holdings.

64 funds tracked by Wall St. Rank hold ISEE as of Q4 2013.

Marshall Wace North America held 19,689 shares of IVERIC bio, Inc. Common Stock worth $637K as of Q4 2013.
IVERIC bio, Inc. Common Stock was a new Marshall Wace North America position in Q4 2013.
IVERIC bio, Inc. Common Stock made up 0.01% of Marshall Wace North America's portfolio in Q4 2013, its #482 holding.
64 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q4 2013.

Based on Marshall Wace North America's 13F filing for Q4 2013, filed 14 Feb 2014.